Issue Information
19 November 2019
Issue Information
19 November 2019
Trefoil Factor Family 1 Inhibits the Development of Hepatocellular Carcinoma by Regulating β‐Catenin Activation
Yosuke Ochiai, Junpei Yamaguchi, Toshio Kokuryo, Yukihiro Yokoyama, Tomoki Ebata, Masato Nagino – 16 November 2019
Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow‐up
Christian S. Alvarez, Barry I. Graubard, Jake E. Thistle, Jessica L. Petrick, Katherine A. McGlynn – 16 November 2019
Corrections
15 November 2019
A Novel Technique of Physiological Portal Inflow Augmentation During Liver Transplantation for Yerdel Grade 4 Portal Vein Thrombosis
Yogesh Puri, Vasanthakumar Gunasekaran, Shiva Kumar Palanisamy, Babu Elangovan, Pradeep Krishna, Balaji Balasubramanian, Anjana Ananth, Mettu Srinivas Reddy, Mohamed Rela – 14 November 2019
Immunosuppression Withdrawal in Liver Transplant Recipients on Sirolimus
Josh Levitsky, Bryna E. Burrell, Sai Kanaparthi, Laurence A. Turka, Sunil Kurian, Alberto Sanchez‐Fueyo, Juan J. Lozano, Anthony Demetris, Andrew Lesniak, Allan D. Kirk, Linda Stempora, Guang‐Yu Yang, James M. Mathew – 13 November 2019
A Microphysiological System for Studying Nonalcoholic Steatohepatitis
Tomasz Kostrzewski, Paloma Maraver, Larissa Ouro‐Gnao, Ana Levi, Sophie Snow, Alina Miedzik, Krista Rombouts, David Hughes – 13 November 2019 – Nonalcoholic steatohepatitis (NASH) is the most severe form of nonalcoholic fatty liver disease (NAFLD), which to date has no approved drug treatments. There is an urgent need for better understanding of the genetic and molecular pathways that underlie NAFLD/NASH, and currently available preclinical models, be they in vivo or in vitro, do not fully represent key aspects of the human disease state.
LiverLearning®: 2019 Hepatitis Debrief
Digest a debrief of the newest data on the treatment of viral hepatitis presented at The Liver Meeting.
LiverLearning®: 2019 Leon Schiff State-of-the-Art Lecture: Molecular Pathogenesis and Management of Hepatocellular Carcinoma
At the 2019 Leon Schiff State-of-the-Art Lecture, our selected speaker will provide a thorough overview of the advances in knowledge of the pathogenesis of hepatocellular carcinoma (HCC). The lecture will explore current data on evidence-based treatment of this disease, including novel molecular therapies and advances in precision oncology.